Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Cantor Fitzgerald
Argus Health
UBS
Merck
Harvard Business School
US Department of Justice
Cipla
Moodys
Mallinckrodt

Generated: January 18, 2018

DrugPatentWatch Database Preview

Actavis Elizabeth Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and twenty-three approved drugs.

There are eight tentative approvals on ACTAVIS ELIZABETH drugs.

Summary for Actavis Elizabeth
US Patents:0
Tradenames:82
Ingredients:82
NDAs:123

Drugs and US Patents for Actavis Elizabeth

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth ALPRAZOLAM alprazolam TABLET, ORALLY DISINTEGRATING;ORAL 078561-002 Mar 16, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth LAMOTRIGINE lamotrigine TABLET, EXTENDED RELEASE;ORAL 200672-001 Oct 17, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET, EXTENDED RELEASE;ORAL 203615-001 Oct 14, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN acetaminophen; propoxyphene napsylate TABLET;ORAL 070910-001 Jan 2, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 074260-001 Sep 3, 1993 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth TIZANIDINE HYDROCHLORIDE tizanidine hydrochloride TABLET;ORAL 076283-001 Jul 12, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth DOXAZOSIN MESYLATE doxazosin mesylate TABLET;ORAL 075574-001 Oct 18, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth PRAMIPEXOLE DIHYDROCHLORIDE pramipexole dihydrochloride TABLET, EXTENDED RELEASE;ORAL 203615-002 Jan 3, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth NIFEDIPINE nifedipine CAPSULE;ORAL 072579-001 Jan 8, 1991 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Elizabeth HYDROCHLOROTHIAZIDE hydrochlorothiazide TABLET;ORAL 085054-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Argus Health
Accenture
Dow
Johnson and Johnson
Medtronic
AstraZeneca
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot